|
|
 |
|
Viewing report
|
|
|
|
Acura Pharmaceuticals, Inc. (ACUR) - Financial and Strategic SWOT Analysis Review
GlobalData, Sep 2011, Pages: 38
Acura Pharmaceuticals, Inc. (ACUR) - Financial and Strategic SWOT Analysis Review
Summary
Acura Pharmaceuticals, Inc. (Acura) is a pharmaceutical company that engaged in the research, development and manufacture of products for the treatment of severe pain using its Aversion Technology (AT) and Impede Technologies. The company's portfolio of pipeline products includes opioid analgesics such as Acurox tablets, Acuracet tablets, Impede PSE (pseudoephedrine HCl) tablets, Acurox with Niacin (oxycodone HCl/niacin) tablets and Vycavert tablets. The company also focuses on expanding its product line to include non-opioid products containing abusable active ingredients, such as sedatives, stimulants and tranquillizers. Operating through a single wholly owned subsidiary, Acura Pharmaceutical Technologies, Inc., Acura is headquartered in Illinois, the US.
Acura Pharmaceuticals, Inc. Key Recent Developments
Jul 28, 2011 Acura Pharmaceuticals Appoints David Azad To Board
Jul 28, 2011 Acura Pharmaceuticals Reports Total Revenue Of $20.2m For Q2 2011
Jul 11, 2011 Acura Pharmaceuticals Appoints Robert Jones As President And CEO
Jul 08, 2011 Acura Pharmaceuticals Announces Retirement Of William Sumner From Board
Jun 06, 2011 Acura Pharmaceuticals Announces Notice Of Allowance For Third Aversion Technology Patent
This comprehensive SWOT profile of Acura Pharmaceuticals, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
King Pharmaceuticals, Inc. (KG) - Financial and Strategic SWOT Analysis Review
Avexa Limited (AVX) - Financial and Strategic SWOT Analysis Review
Onyx Pharmaceuticals, Inc. (ONXX) - Financial and Strategic SWOT Analysis Review
KV Pharmaceutical Company (KV.A) - Financial and Strategic SWOT Analysis Review
Radient Pharmaceuticals Corporation (RXPC) - Financial and Strategic SWOT Analysis Review
Labopharm Inc. (DDS) - Financial and Strategic SWOT Analysis Review
Valeant Pharmaceuticals International, Inc. (VRX) - Financial and Strategic SWOT Analysis Review
AKELA Pharma Inc. (AKLPF) - Financial and Strategic SWOT Analysis Review
Cubist Pharmaceuticals, Inc. (CBST) - Financial and Strategic SWOT Analysis Review
Hospira, Inc. (HSP) - Financial and Strategic SWOT Analysis Review
|
|
|
|
